-
1
-
-
0013767845
-
Tumors of the breast related to the oestrin hormone
-
Geschickter CF, Lewis D, Hartman CG. Tumors of the breast related to the oestrin hormone. Am J Cancer 1934; 21: 828-859
-
(1934)
Am J Cancer
, vol.21
, pp. 828-859
-
-
Geschickter, C.F.1
Lewis, D.2
Hartman, C.G.3
-
2
-
-
37549001360
-
Adjuvant hormonal therapy for premenopausal women with breast cancer
-
Brown RJ, Davidson NE. Adjuvant hormonal therapy for premenopausal women with breast cancer. Sem Oncol 2006; 33: 657-663
-
(2006)
Sem Oncol
, vol.33
, pp. 657-663
-
-
Brown, R.J.1
Davidson, N.E.2
-
3
-
-
84863408216
-
Integrative analysis of response to tamoxifen treatment in ER-positive breast cancer using GWAS information and transcription profiling
-
Hicks C, Kumar R, Pannuti A, Miele L. Integrative analysis of response to tamoxifen treatment in ER-positive breast cancer using GWAS information and transcription profiling. Breast Cancer 2012; 6: 47-66
-
(2012)
Breast Cancer
, vol.6
, pp. 47-66
-
-
Hicks, C.1
Kumar, R.2
Pannuti, A.3
Miele, L.4
-
4
-
-
69249137029
-
Biological determinants of endocrine resistance in breast cancer
-
Musgrove EA, Sutherland RL. Biological determinants of endocrine resistance in breast cancer. Nat Rev Cancer 2009; 9: 631-643
-
(2009)
Nat Rev Cancer
, vol.9
, pp. 631-643
-
-
Musgrove, E.A.1
Sutherland, R.L.2
-
5
-
-
79960832381
-
The different roles of ER subtypes in cancer biology and therapy
-
Thomas C, Gustafsson JA. The different roles of ER subtypes in cancer biology and therapy. Nat RevCancer 2011; 11: 597-608
-
(2011)
Nat RevCancer
, vol.11
, pp. 597-608
-
-
Thomas, C.1
Gustafsson, J.A.2
-
6
-
-
0035042153
-
Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumor progression in invasive ductal carcinoma of the breast
-
Wong SC, Chan JK, Lee KC, Hsiao WL. Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumor progression in invasive ductal carcinoma of the breast. J Pathol 2001; 194: 35-42
-
(2001)
J Pathol
, vol.194
, pp. 35-42
-
-
Wong, S.C.1
Chan, J.K.2
Lee, K.C.3
Hsiao, W.L.4
-
7
-
-
0034238115
-
Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen- mediated cell cycle arrest in human breast cancer cells
-
Cariou S, Donovan JC, Flanagan WM, Milic A, Bhattacharya N, Slingerland JM. Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells. Proc Natl Acad Sci USA 2000; 97: 9042-9046
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 9042-9046
-
-
Cariou, S.1
Donovan, J.C.2
Flanagan, W.M.3
Milic, A.4
Bhattacharya, N.5
Slingerland, J.M.6
-
8
-
-
0036174231
-
Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-Alpha and Ki-67 expression
-
Shaaban AM, Sloane JP, West CR, Foster CS. Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-Alpha and Ki-67 expression. Am J Pathol 2002; 160: 597-604
-
(2002)
Am J Pathol
, vol.160
, pp. 597-604
-
-
Shaaban, A.M.1
Sloane, J.P.2
West, C.R.3
Foster, C.S.4
-
9
-
-
84864085607
-
Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression
-
Lindstrom LS, Karlsson E, Wilking UM, Johansson U, Hartman J, Lidbrink EK et al. Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression. J Clin Oncol 2012; 30: 2601-2608
-
(2012)
J Clin Oncol
, vol.30
, pp. 2601-2608
-
-
Lindstrom, L.S.1
Karlsson, E.2
Wilking, U.M.3
Johansson, U.4
Hartman, J.5
Lidbrink, E.K.6
-
10
-
-
34347262483
-
Differential regulation of estrogen receptor alpha turnover and transactivation by Mdm2 and stress-inducing agents
-
Duong V, Boulle N, Daujat S, Chauvet J, Bonnet S, Neel H et al. Differential regulation of estrogen receptor alpha turnover and transactivation by Mdm2 and stress-inducing agents. Cancer Res 2007; 67: 5513-5521
-
(2007)
Cancer Res
, vol.67
, pp. 5513-5521
-
-
Duong, V.1
Boulle, N.2
Daujat, S.3
Chauvet, J.4
Bonnet, S.5
Neel, H.6
-
11
-
-
73549123450
-
BRCA1 regulates acetylation and ubiquitination of estrogen receptor-Alpha
-
Ma Y, Fan S, Hu C, Meng Q, Fuqua SA, Pestell RG et al. BRCA1 regulates acetylation and ubiquitination of estrogen receptor-Alpha. Mol Endocrinol 2010; 24: 76-90
-
(2010)
Mol Endocrinol
, vol.24
, pp. 76-90
-
-
Ma, Y.1
Fan, S.2
Hu, C.3
Meng, Q.4
Fuqua, S.A.5
Pestell, R.G.6
-
12
-
-
0037351881
-
Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling
-
Reid G, Hubner MR, Metivier R, Brand H, Denger S, Manu D et al. Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol Cell 2003; 11: 695-707
-
(2003)
Mol Cell
, vol.11
, pp. 695-707
-
-
Reid, G.1
Hubner, M.R.2
Metivier, R.3
Brand, H.4
Denger, S.5
Manu, D.6
-
13
-
-
28144439277
-
CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptoralpha
-
Fan M, Park A, Nephew KP. CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptoralpha. Mol Endocrinol 2005; 19: 2901-2914
-
(2005)
Mol Endocrinol
, vol.19
, pp. 2901-2914
-
-
Fan, M.1
Park, A.2
Nephew, K.P.3
-
14
-
-
81255186483
-
Cracking the estrogen receptor's posttranslational code in breast tumors
-
Le Romancer M, Poulard C, Cohen P, Sentis S, Renoir JM, Corbo L. Cracking the estrogen receptor's posttranslational code in breast tumors. Endocr Rev 2011; 32: 597-622
-
(2011)
Endocr Rev
, vol.32
, pp. 597-622
-
-
Le Romancer, M.1
Poulard, C.2
Cohen, P.3
Sentis, S.4
Renoir, J.M.5
Corbo, L.6
-
15
-
-
84860389938
-
A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation
-
Brekman A, Singh KE, Polotskaia A, Kundu N, Bargonetti J. A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation. Breast Cancer Res 2011; 13: R3
-
(2011)
Breast Cancer Res
, vol.13
-
-
Brekman, A.1
Singh, K.E.2
Polotskaia, A.3
Kundu, N.4
Bargonetti, J.5
-
17
-
-
46349108800
-
Estrogen receptor-Alpha hinge-region lysines 302 and 303 regulate receptor degradation by the proteasome
-
Berry NB, Fan M, Nephew KP. Estrogen receptor-Alpha hinge-region lysines 302 and 303 regulate receptor degradation by the proteasome. Mol Endocrinol 2008; 22: 1535-1551
-
(2008)
Mol Endocrinol
, vol.22
, pp. 1535-1551
-
-
Berry, N.B.1
Fan, M.2
Nephew, K.P.3
-
18
-
-
48849086403
-
SRC-3 transcription-coupled activation degradation, and the ubiquitin clock: Is there enough coactivator to go around in cells?
-
Lonard DM, O'Malley BW. SRC-3 transcription-coupled activation, degradation, and the ubiquitin clock: Is there enough coactivator to go around in cells? Sci Signaling 2008; 1: Pe16
-
(2008)
Sci Signaling
, vol.1
-
-
Lonard, D.M.1
O'malley, B.W.2
-
19
-
-
79954421269
-
17Beta-Estradiol-induced cell proliferation requires estrogen receptor (ER) alpha monoubiquitination
-
La Rosa P, Pesiri V, Marino M, Acconcia F. 17beta-Estradiol-induced cell proliferation requires estrogen receptor (ER) alpha monoubiquitination. Cell Signalling 2011; 23: 1128-1135
-
(2011)
Cell Signalling
, vol.23
, pp. 1128-1135
-
-
La Rosa, P.1
Pesiri, V.2
Marino, M.3
Acconcia, F.4
-
20
-
-
1842850748
-
Identification of the protein Zibra, its genomic organization, regulation, and expression in breast cancer cells
-
Thompson HG, Harris JW, Lin L, Brody JP. Identification of the protein Zibra, its genomic organization, regulation, and expression in breast cancer cells. Exp Cell Res 2004; 295: 448-459
-
(2004)
Exp Cell Res
, vol.295
, pp. 448-459
-
-
Thompson, H.G.1
Harris, J.W.2
Lin, L.3
Brody, J.P.4
-
21
-
-
79953239980
-
SHARPIN forms a linear ubiquitin ligase complex regulating NF-kappaB activity and apoptosis
-
Ikeda F, Deribe YL, Skanland SS, Stieglitz B, Grabbe C, Franz-Wachtel M et al. SHARPIN forms a linear ubiquitin ligase complex regulating NF-kappaB activity and apoptosis. Nature 2011; 471: 637-641
-
(2011)
Nature
, vol.471
, pp. 637-641
-
-
Ikeda, F.1
Deribe, Y.L.2
Skanland, S.S.3
Stieglitz, B.4
Grabbe, C.5
Franz-Wachtel, M.6
-
22
-
-
79953237668
-
SHARPIN is a component of the NF-kappaB-Activating linear ubiquitin chain assembly complex
-
Tokunaga F, Nakagawa T, Nakahara M, Saeki Y, Taniguchi M, Sakata S et al. SHARPIN is a component of the NF-kappaB-Activating linear ubiquitin chain assembly complex. Nature 2011; 471: 633-636
-
(2011)
Nature
, vol.471
, pp. 633-636
-
-
Tokunaga, F.1
Nakagawa, T.2
Nakahara, M.3
Saeki, Y.4
Taniguchi, M.5
Sakata, S.6
-
23
-
-
59649103156
-
Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation
-
Tokunaga F, Sakata S, Saeki Y, Satomi Y, Kirisako T, Kamei K et al. Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat Cell Biolo 2009; 11: 123-132
-
(2009)
Nat Cell Biolo
, vol.11
, pp. 123-132
-
-
Tokunaga, F.1
Sakata, S.2
Saeki, Y.3
Satomi, Y.4
Kirisako, T.5
Kamei, K.6
-
24
-
-
33748296223
-
BARX2 and estrogen receptor-Alpha (ESR1) coordinately regulate the production of alternatively spliced ESR1 isoforms and control breast cancer cell growth and invasion
-
Stevens TA, Meech R. BARX2 and estrogen receptor-Alpha (ESR1) coordinately regulate the production of alternatively spliced ESR1 isoforms and control breast cancer cell growth and invasion. Oncogene 2006; 25: 5426-5435
-
(2006)
Oncogene
, vol.25
, pp. 5426-5435
-
-
Stevens, T.A.1
Meech, R.2
-
25
-
-
84877028141
-
Comprehensive molecular portraits of human breast tumours
-
TCGA
-
TCGA. Comprehensive molecular portraits of human breast tumours. Nature 2012; 490: 61-70
-
(2012)
Nature
, vol.490
, pp. 61-70
-
-
-
26
-
-
79151483638
-
An online survival analysis tool to rapidly assess the effect of 22 277 genes on breast cancer prognosis using microarray data of 1809 Patients
-
Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q et al. An online survival analysis tool to rapidly assess the effect of 22 277 genes on breast cancer prognosis using microarray data of 1809 patients. Breast Cancer Res Treat 2010; 123: 725-731
-
(2010)
Breast Cancer Res Treat
, vol.123
, pp. 725-731
-
-
Gyorffy, B.1
Lanczky, A.2
Eklund, A.C.3
Denkert, C.4
Budczies, J.5
Li, Q.6
-
27
-
-
64649091704
-
E3 ubiquitin ligase RNF31 cooperates with DAX-1 in transcriptional repression of steroidogenesis
-
Ehrlund A, Anthonisen EH, Gustafsson N, Venteclef N, Robertson Remen K, Damdimopoulos AE et al. E3 ubiquitin ligase RNF31 cooperates with DAX-1 in transcriptional repression of steroidogenesis. Mol Cell Biol 2009; 29: 2230-2242
-
(2009)
Mol Cell Biol
, vol.29
, pp. 2230-2242
-
-
Ehrlund, A.1
Anthonisen, E.H.2
Gustafsson, N.3
Venteclef, N.4
Robertson Remen, K.5
Damdimopoulos, A.E.6
-
28
-
-
84857929663
-
Knockdown of SF-1 and RNF31 affects components of steroidogenesis TGFbeta, and Wnt/beta-catenin signaling in adrenocortical carcinoma cells
-
Ehrlund A, Jonsson P, Vedin LL, Williams C, Gustafsson JA, Treuter E. Knockdown of SF-1 and RNF31 affects components of steroidogenesis, TGFbeta, and Wnt/beta-catenin signaling in adrenocortical carcinoma cells. PLoS One 2012; 7: E32080
-
(2012)
PLoS One
, vol.7
-
-
Ehrlund, A.1
Jonsson, P.2
Vedin, L.L.3
Williams, C.4
Gustafsson, J.A.5
Treuter, E.6
-
29
-
-
71549124954
-
Positive cross-Talk between estrogen receptor and NF-kappaB in breast cancer
-
Frasor J, Weaver A, Pradhan M, Dai Y, Miller LD, Lin CY et al. Positive cross-Talk between estrogen receptor and NF-kappaB in breast cancer. Cancer Res 2009; 69: 8918-8925
-
(2009)
Cancer Res
, vol.69
, pp. 8918-8925
-
-
Frasor, J.1
Weaver, A.2
Pradhan, M.3
Dai, Y.4
Miller, L.D.5
Lin, C.Y.6
-
30
-
-
40949084787
-
NFkappaB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses
-
Nettles KW, Bruning JB, Gil G, Nowak J, Sharma SK, Hahm JB et al. NFkappaB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses. Nat Chem Biol 2008; 4: 241-247
-
(2008)
Nat Chem Biol
, vol.4
, pp. 241-247
-
-
Nettles, K.W.1
Bruning, J.B.2
Gil, G.3
Nowak, J.4
Sharma, S.K.5
Hahm, J.B.6
-
32
-
-
84867096523
-
The E3 ligase HOIP specifies linear ubiquitin chain assembly through its RING-IBR-RING domain and the unique LDD extension
-
Smit JJ, Monteferrario D, Noordermeer SM, Van Dijk WJ, Van Der Reijden BA, Sixma TK. The E3 ligase HOIP specifies linear ubiquitin chain assembly through its RING-IBR-RING domain and the unique LDD extension. EMBO J 2012; 31: 3833-3844
-
(2012)
EMBO J
, vol.31
, pp. 3833-3844
-
-
Smit, J.J.1
Monteferrario, D.2
Noordermeer, S.M.3
Van Dijk, W.J.4
Van Der Reijden, B.A.5
Sixma, T.K.6
-
33
-
-
33750219981
-
A ubiquitin ligase complex assembles linear polyubiquitin chains
-
Kirisako T, Kamei K, Murata S, Kato M, Fukumoto H, Kanie M et al. A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J 2006; 25: 4877-4887
-
(2006)
EMBO J
, vol.25
, pp. 4877-4887
-
-
Kirisako, T.1
Kamei, K.2
Murata, S.3
Kato, M.4
Fukumoto, H.5
Kanie, M.6
-
34
-
-
84863066878
-
Calpain-mediated processing of p53-Associated parkin-like cytoplasmic protein (PARC) affects chemosensitivity of human ovarian cancer cells by promoting p53 subcellular trafficking
-
Woo MG, Xue K, Liu J, McBride H, Tsang BK. Calpain-mediated processing of p53-Associated parkin-like cytoplasmic protein (PARC) affects chemosensitivity of human ovarian cancer cells by promoting p53 subcellular trafficking. J Biol Chem 2012; 287: 3963-3975
-
(2012)
J Biol Chem
, vol.287
, pp. 3963-3975
-
-
Woo, M.G.1
Xue, K.2
Liu, J.3
McBride, H.4
Tsang, B.K.5
-
35
-
-
78649293245
-
P53-Associated Parkin-like cytoplasmic protein (Parc) short-interfering RNA (siRNA) alters p53 location and biology of Peyronie's disease fibroblasts
-
Mulhall JP, Barnas J, Kobylarz K, Mueller A. p53-Associated Parkin-like cytoplasmic protein (Parc) short-interfering RNA (siRNA) alters p53 location and biology of Peyronie's disease fibroblasts. BJU Int 2010; 106: 1706-1713
-
(2010)
BJU Int
, vol.106
, pp. 1706-1713
-
-
Mulhall, J.P.1
Barnas, J.2
Kobylarz, K.3
Mueller, A.4
-
36
-
-
70449519412
-
Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease
-
da Costa CA, Sunyach C, Giaime E, West A, Corti O, Brice A et al. Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease. Nature Cell Biol 2009; 11: 1370-1375
-
(2009)
Nature Cell Biol
, vol.11
, pp. 1370-1375
-
-
Da Costa, C.A.1
Sunyach, C.2
Giaime, E.3
West, A.4
Corti, O.5
Brice, A.6
-
37
-
-
0037428083
-
Parc-ing p53 in the cytoplasm
-
Kastan MB, Zambetti GP. Parc-ing p53 in the cytoplasm. Cell 2003; 112: 1-2
-
(2003)
Cell
, vol.112
, pp. 1-2
-
-
Kastan, M.B.1
Zambetti, G.P.2
-
38
-
-
76249094935
-
RBCK1 drives breast cancer cell proliferation by promoting transcription of estrogen receptor alpha and cyclin B1
-
Gustafsson N, Zhao C, Gustafsson JA, Dahlman-Wright K. RBCK1 drives breast cancer cell proliferation by promoting transcription of estrogen receptor alpha and cyclin B1. Cancer Res 2010; 70: 1265-1274
-
(2010)
Cancer Res
, vol.70
, pp. 1265-1274
-
-
Gustafsson, N.1
Zhao, C.2
Gustafsson, J.A.3
Dahlman-Wright, K.4
-
39
-
-
0022500953
-
Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: A European multicenter study
-
Leclercq G, Bojar H, Goussard J, Nicholson RI, Pichon MF, Piffanelli A et al. Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: A European multicenter study. Cancer Res 1986; 46: 4233s-4236s.
-
(1986)
Cancer Res
, vol.46
-
-
Leclercq, G.1
Bojar, H.2
Goussard, J.3
Nicholson, R.I.4
Pichon, M.F.5
Piffanelli, A.6
-
40
-
-
84866320302
-
Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells
-
Putnik M, Zhao C, Gustafsson JA, Dahlman-Wright K. Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells. Biochem Biophys Res Commun 2012; 426: 26-32
-
(2012)
Biochem Biophys Res Commun
, vol.426
, pp. 26-32
-
-
Putnik, M.1
Zhao, C.2
Gustafsson, J.A.3
Dahlman-Wright, K.4
-
41
-
-
34248586255
-
Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells
-
Zhao C, Matthews J, Tujague M, Wan J, Strom A, Toresson G et al. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells. Cancer Res 2007; 67: 3955-3962
-
(2007)
Cancer Res
, vol.67
, pp. 3955-3962
-
-
Zhao, C.1
Matthews, J.2
Tujague, M.3
Wan, J.4
Strom, A.5
Toresson, G.6
|